Holli Cherevka

COO
Ampio Pharmaceuticals
(NYSE American: AMPE)

Holli joined Ampio Pharmaceuticals in 2013, and prior to taking her current role, she served as the company’s vice president of operations and oversaw clinical, regulatory and manufacturing operations. She has held roles of increasing responsibility throughout her career including site leadership, strategic planning, contractor management, and product portfolio leadership.

Previously, Holli was the Director of Business Development at the American College of Radiology (ACR) Image Metrix. Holli earned a Bachelor of Arts from California State University, Chico, and holds a Master’s of Science in Biomedical and Molecular Sciences Research from King’s College, London.

Holli is a member of the Parenteral Drug Association, Colorado Bioscience Association and the International Society of Pharmaceutical Engineers, and has represented Ampio Pharmaceuticals at conferences for the International Society of Pharmaceutical Engineers as well as at Global Investment Conferences.